Cell-Based Assays Market Overview, Growth, Trends, Demand Forecast Report
Cell-based
assays are commonly used analytical tools to measure the cell proliferation,
viability, cytotoxicity, production and screening of compounds. Owing to the
rise in cases of chronic disorders and increasing inclination of the government
organizations and private firms funding in the health sector, there has been a
consistent high demand of new therapeutic drug discovery. In this regard, the
cell-based assays have advantage over the conventional animal based models for
drug discovery. Cell-based assays utilizes live cell models to investigate the
cellular mechanism when exposed to external stimuli and provide precise
information about the intracellular molecular targets required in drug
discovery screening. In contrary to the animal based methods, the
resultant toxicity and safety measures in cell based assays are monitored at an
early stage of an experiment, hence it reduces the additional cost that can be
generated due to high failure rates if monitored at a later stage of an
experiment. In combination to high-throughput screening techniques, cell- based
assays have gained its interest in the area of research and development for
primary as well as secondary screening.
However, cell-based assay’s experimental
instruments and kits are expensive and require high skilled professionals to
conduct the procedures as the cost of experimental procedure is relatively
high. This acts as one of the key restraining factors governing the cell-basedassays markets.
The
cell-based assays market is segmented based on product, application, and end
user. On the basis of product, the market is categorised into consumables,
instruments, services, and software. Consumables is further sub-categorised
into reagents, assays kits, microplates, cell lines, probes and labels and
other consumables, and is expected contribute the largest share to the global
market in 2016.
Download
Free Sample of This Research Report: https://www.psmarketresearch.com/market-analysis/cell-based-assays-market/report-sample
The global
cell-based assays market is anticipated to grow on account of rise in the
incidence of chronic diseases, increasing public and private intervention in
the area of research and development, inclination towards cell-based assays
over traditional biochemical assays, and a sustained increase in the drug
discovery activity. According to the Centers for Disease Control and
Prevention, 7 out of ten causes of death were due to chronic ailments, in 2014.
Additionally, the cell-based assay techniques have many advantages over
conventional methodology. The continuous advancement in technological products
under cell-based assay along with their cost effectiveness are the major
drivers of the growth of global cell-based assays market.
Make
Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=cell-based-assays-market
Some of
the other major players operating in the global cell-based assays market
include Merck KGaA, Becton, Dickinson and Company, Promega Corporation, Danaher
Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Cell Signaling
Technology, Inc., BioTek Instruments Inc., Lonza Group, ProQinase GmbH, Charles
River Laboratories Inc, Cisbio Bioassays, Miltenyi Biotec, Cell Biolabs,
Inc., DiscoverX Corporation, BioAgilytix Labs., Enzo Life Sciences, Inc.,
Aurelia Bioscience Ltd., Selexis SA, and QGel SA.
Contact:
Mr. Kundan Kumar
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886
(USA/Canada)
Email: enquiry@psmarketresearch.com
Comments
Post a Comment